Active	Status	Sponsor type	Region	Phase	Filter
8 Active 1 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yan, Sheng
ENREACH-PDAC-01, NCT05149326: KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.	Active, not recruiting	3	408	RoW	KN046, placebo	Jiangsu Alphamab Biopharmaceuticals Co., Ltd	Advanced Pancreatic Ductal Adenocarcinoma	04/24	08/24
NCT06560827: CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection	Recruiting	1	30	RoW	CT011 CAR-GPC3 T Cells Injection	CARsgen Therapeutics Co., Ltd., Shanghai Zhongshan Hospital	HCC	12/26	06/27
Ma, Xi
No trials found